Housing Development Finance Corporation Ltd:企業のM&A・事業提携・投資動向

◆英語タイトル:Housing Development Finance Corporation Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1332
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:156
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Housing Development Finance Corporation Ltd – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Housing Development Finance Corporation Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Housing Development Finance Corporation Ltd since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Housing Development Finance Corporation Ltd’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Housing Development Finance Corporation Ltd. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Housing Development Finance Corporation Ltd’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Housing Development Finance Corporation Ltd and its subsidiaries since 2007.
- Information about key financial and legal advisors for Housing Development Finance Corporation Ltd’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Housing Development Finance Corporation Ltd’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Deal reports 8
CORPORATE VENTURING 38
Corporate Venturing – Overview 38
Corporate Venturing – Deal reports 39
CAPITAL RAISING 58
Capital Raising – Overview 58
Capital Raising – Deal reports 59
DIVESTMENTS 100
Divestments – Overview 100
Divestments – Deal reports 101
PRIVATE EQUITY & OWNERSHIP 142
Private Equity and Ownership – Deal reports 142
APPENDIX 146
Contact Us 146
About MarketLine Financial Deals Database 146
Deal Definition and Methodology 148
About MarketLine 155

List of Tables
Table 1: Housing Development Finance Corporation Limited corporate venturing volume and value trend (2014-YTD2018)
Table 2: Housing Development Finance Corporation Limited corporate venturing by geography (2014-YTD2018)
Table 3: Housing Development Finance Corporation Limited capital raising volume and value trend (2014-YTD2018)
Table 4: Housing Development Finance Corporation Limited capital raising by deal type (2014-YTD2018)
Table 5: Housing Development Finance Corporation Limited divestments volume and value trend (2014-YTD2018)
Table 6: Housing Development Finance Corporation Limited divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Housing Development Finance Corporation Limited corporate venturing volume and value trend (2014-YTD2018)
Figure 2: Housing Development Finance Corporation Limited corporate venturing by geography (2014-YTD2018)
Figure 3: Housing Development Finance Corporation Limited capital raising volume and value trend (2014-YTD2018)
Figure 4: Housing Development Finance Corporation Limited capital raising by deal type (2014-YTD2018)
Figure 5: Housing Development Finance Corporation Limited divestments volume and value trend (2014-YTD2018)
Figure 6: Housing Development Finance Corporation Limited divestments by geography (2014-YTD2018)

★海外企業調査レポート[Housing Development Finance Corporation Ltd:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ConMed Corporation (CNMD):企業の財務・戦略的SWOT分析
    ConMed Corporation (CNMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Intellia Therapeutics Inc (NTLA):企業の財務・戦略的SWOT分析
    Summary Intellia Therapeutics Inc (Intellia Therapeutics) is a genome editing company. It develops proprietary curative therapeutics using CRISPR/Cas9 technology. The company develops in vivo programs for the treatment of liver diseases such as alpha-1 antitrypsin deficiency, and primary hyperoxalur …
  • Enteris BioPharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Enteris BioPharma Inc (Enteris) is a biotechnology company that offers formulation solutions based on proprietary drug delivery technologies. The company’s product candidate includes oral leuprolide tablet, which is developed for endometriosis in women. Its other product candidates comprise …
  • Cal-Maine Foods Inc (CALM):企業の財務・戦略的SWOT分析
    Cal-Maine Foods Inc (CALM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Multi-Color Corp (LABL):企業の財務・戦略的SWOT分析
    Summary Multi-Color Corp (Multi-Color) is a paper and packaging company that develops, manufactures and markets packaging labels. The company offers products such as self adhesive, RFID and NFC, decals and overlays, luminescent, membrane switches, nameplates and signage, foams and gaskets, domed lab …
  • Wincor Nixdorf AG:企業の戦略・SWOT・財務情報
    Wincor Nixdorf AG - Strategy, SWOT and Corporate Finance Report Summary Wincor Nixdorf AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Verseon Corp (VSN):企業の財務・戦略的SWOT分析
    Summary Verseon Corp (Verseon) is a pharmaceutical company that develops novel therapeutics. The company develops drug programs in the therapeutic areas of anticoagulation, diabetic macular edema, hereditary angioedema, and oncology. Its anticoagulation program develops oral anticoagulants for cardi …
  • Top Frontier Investment Holdings Inc:企業の戦略・SWOT・財務分析
    Top Frontier Investment Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Top Frontier Investment Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Spherix Inc (SPEX):企業の財務・戦略的SWOT分析
    Spherix Inc (SPEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Guangzhou Institute of Biomedicine and Health-製薬・医療分野:企業M&A・提携分析
    Summary Guangzhou Institute of Biomedicine and Health (GIBH) is a research institute that conducts research on stem cell and regenerative medicine, chemical biology, infection and immunity, public health and scientific research equipment development. The institute’s life process and disease mechanis …
  • Alimentation Couche-Tard Inc (ATD.B):石油・ガス:M&Aディール及び事業提携情報
    Summary Alimentation Couche-Tard Inc (Couche-Tard) is a retail company that operates an extensive network of convenience stores. The company principally offers food and non-food items as well as transportation fuels. Couche-Tard products include tobacco, alcohol, grocery items, candy, snacks and var …
  • HemaCare Corp (HEMA):企業の財務・戦略的SWOT分析
    Summary HemaCare Corp (HemaCare) is a provider of biological blood products and services. The company offers primary blood cells and tissues derived from normal and mobilized peripheral blood, cord blood, and bone marrow. It spans its expertise in isolations, custom cell collections and testing of p …
  • Azimut Exploration Inc (AZM):企業の財務・戦略的SWOT分析
    Summary Azimut Exploration Inc (AEI) is a mining company that offers exploration and development of mineral resources. The company carries out the business of acquisition, exploration, and development of gold, copper, silver, chromium, uranium and rare earth element properties. It also offers projec …
  • MedImmune LLC:企業の戦略的SWOT分析
    MedImmune LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Zurich Insurance Group Ltd:企業のM&A・事業提携・投資動向
    Zurich Insurance Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Zurich Insurance Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Coherus BioSciences Inc (CHRS):企業の財務・戦略的SWOT分析
    Summary Coherus BioSciences Inc (Coherus) is a biosimilar platform company that develops and commercializes biosimilar drugs. The company’s pipeline product candidates include CHS-1701, an pegfilgrastim used to treat febrile neutropenia; CHS-0214, is an etanercept biosimilar candidate which is used …
  • Vale Canada Ltd:企業の戦略・SWOT・財務分析
    Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report Summary Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Korn Ferry (KFY):企業の財務・戦略的SWOT分析
    Korn Ferry (KFY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Glorious Sun Enterprises Limited (393):企業の財務・戦略的SWOT分析
    Glorious Sun Enterprises Limited (393) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Catalyst Biosciences Inc (CBIO)-医療機器分野:企業M&A・提携分析
    Summary Catalyst Biosciences Inc (Catalyst), formerly Targacept Inc is a clinical-stage biopharmaceutical company that develops novel medicines to address hematology indications. The company discovers and develops next generation biopharmaceuticals based on engineered human proteases platform techno …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆